SEC Form 4 · accession 0001437749-15-000560
Impax Laboratories, LLC · IPXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leslie Z Benet
Director
Period of report
Jan 9, 2015
Accepted (ET)
Jan 12, 2015 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001003642
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 8,100 | D | ||
| Common Stock | holding | — | — | — | 600 | I | By The Benet Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right-to-Buy)F1 | $35.89 | Jan 9, 2015 | A | 2,750 | A | Jan 9, 2015 | Jan 9, 2020 | Common Stock | 2,750 | 2,750 | D |
Explanation of responses
- F1The option is fully vested and exercisable as of the grant date of January 9, 2015
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.